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Abstract 
 
The effects of chronic long term exposure to multiply-polluted environments on fish 
are not well understood, but environmental surveys suggest that such exposure may cause a 
variety of pathologies, including cancers. Transcriptomic profiling has recently been used to 
assess gene expression in European flounder (Platichthys flesus) living in several polluted 
and clean estuaries. However, the gene expression changes detected were not unequivocally 
elicited by pollution, most likely due to the confounding effects of natural estuarine 
ecosystem variables. In this study flounder from an uncontaminated estuary were held on 
clean or polluted sediments in mesocosms, allowing control of variables such as salinity, 
temperature, and diet. After 7 months flounder were removed from each mesocosm and 
hepatocytes prepared from fish exposed to clean or polluted sediments. The hepatocytes 
were treated with benzo(a)pyrene (BAP), estradiol (E2), copper, a mixture of these three, or 
with the vehicle DMSO. A flounder cDNA microarray was then used to measure hepatocyte 
transcript abundance after each treatment. The results show that long term chronic exposure 
to a multiply-polluted sediment causes increases in the expression of mRNAs coding for 
proteins of the endogenous apoptotic program, of innate immunity and inflammation. 
Contrary to expectation, the expression of mRNAs which are commonly used as biomarkers 
of environmental exposure to particular contaminants were not changed, or were changed 
contrary to expectation. However, acute treatment of hepatocytes from flounder from both 
clean and polluted sediments with BAP or E2 caused the expected changes in the expression 
of these biomarkers. Thus transcriptomic analysis of flounder exposed long-term to chronic 
pollution causes a different pattern of gene expression than in fish acutely treated with single 
chemicals, and reveals novel potential biomarkers of environmental contaminant exposure. 
These novel biomarkers include Diablo, a gene involved in apoptotic pathways and highly 
differentially regulated by both chronic and acute exposure to multiple pollutants. 
 
1. Introduction 
 
Estuarine sediments are sinks for chemical pollutants present in industrial and 
domestic effluents, and the health of fish which live in polluted estuaries is of concern. The 
European flounder lives in close association with estuarine sediments and is a key sentinel 
species for biological effects monitoring in initiatives such as the OSPAR Joint Assessment 
and Monitoring Programme (OSPAR, 2003). Such biological effects monitoring 
programmes have concentrated on the use of biochemical, molecular, histopathological and 
morphological biomarkers to indicate exposure to harmful pollutants (van der Oost et al., 
2003). The development of these biomarkers has most often been based on identifying 
endpoints which vary after single acute experimental exposure to model pollutants, such as 
polycyclic aromatic hydrocarbons (PAH), halogenated aromatic hydrocarbons, estrogenic 
chemicals, and metals. However, changes in these markers are not always observed in field 
surveys, even in fish exposed to high levels of contaminants (Eggens et al., 1996) (Reynolds 
et al., 2003).  
The development of transcriptomic techniques for massively parallel, simultaneous 
measurement of expression of several thousands of genes may provide a means to assess, not 
only exposure but also mechanisms of action and effects of environmental contaminants. 
Transcriptomic profiling with targeted microarrays has been used to assess the effects of 
exposure to polluted sediments and in some of these studies it has been possible to obtain a 
toxicologically relevant signal from amongst the transcripts which were changed. Thus, 
when comparing a highly PAH-contaminated environment with a ‘clean’ reference site, 
flounder transcripts characteristic of acute PAH-response were changed (Williams et al., 
2003). Similarly, when comparing hornyhead turbot (Pleuronichthys verticalis) from a site 
receiving an estrogenic effluent with a clean site, a signal characteristic of acute estrogen 
exposure was observed (Baker et al., 2009). However, in a larger study, involving several 
European estuaries of differing pollutant status, and using a more comprehensive microarray, 
a transcriptomic signal of pollutant effect was less clear (Falciani et al., 2008). These results 
demonstrated that gene expression profiles depended on site, and that the relative expression 
levels of a subset of 17 genes could predict the source of flounder with high accuracy. 
However, this subset only contained one currently described biomarker, CYP1A, and 
furthermore transcriptomic profiling of flounder experimentally exposed to acute doses of 
model pollutants (Williams et al., 2008) showed large differences to gene expression profiles 
in fish from polluted environments. These results have general similarities to studies on 
populations of Fundulus heteroclitus, a fish which inhabits severely contaminated estuarine 
sites in North America. Comparing gene expression profiles of F. heteroclitus from several 
polluted and unpolluted sites indicates that in each of the polluted populations 5 to 17% of 
genes are differentially expressed, yet only two genes had a consistent difference in 
expression among all polluted sites (Fisher and Oleksiak, 2007). Also notable was an 
apparent under-representation of the type of biomarker genes which might have been 
expected to be differentially expressed between polluted and unpolluted sites, although in the 
case of F. heteroclitus there appears to be a heritable resistance to the effects of some 
contaminants, which is believed to prevent CYP1A induction for example (Oleksiak, 2008).   
 It is perhaps not surprising that comparing gene expression in different populations 
of fish from different locations is not straightforward. Estuaries in particular are highly 
variable environments and it is possible that pollutant responses are masked by large changes 
in expression of other genes that may be responsive to variables such as salinity, 
temperature, feeding, and, as shown with F. heteroclitus, population differences. It is also 
possible that the long-term response to living on multiply-polluted sediments differs from 
the response to acute, short-term, single-chemical exposures which have been used to 
identify many of the current commonly used molecular and biochemical biomarkers. The 
aim of the study reported here was to compare the transcriptomic effects of chronic exposure 
to a real polluted estuarine sediment with a real ‘clean’ sediment in a single population of 
flounder. This was achieved by chronic exposure in a controlled mesocosm study designed 
to eliminate many of the variables present in different estuaries, followed by microarray and 
quantitative PCR measurement of gene expression in isolated hepatocytes from exposed and 
unexposed fish. The use of isolated hepatocytes provided a means to directly compare the 
transcriptomic effects of acute exposure to prototypical pollutants with long-term chronic 
exposure to sediments, whilst minimizing the effects of natural genetic and environmental 
variation in outbred wild populations of fish. 
 
2. Methods 
 
2.1. Experimental animals 
 
Juvenile (0-group) flounder, were collected by beam trawl at low tide in May-June 
from the Ythan estuary (NE Scotland). Benthic invertebrates (mostly Tellina and Macoma 
bivalves, together with some polychaete worms) were collected by wet sieving (4 mm) from 
clean sediment at the Ythan estuary, Loch Ewe (NW Scotland), and at Balmerino on the 
Firth of Tay estuary (E Scotland). 
 
2.2. Mesocosm Establishment 
The mesocosms consisted of four 1.5 m tanks contained 4-5 cm of test sediment over 
~3 cm of filter sand, covering ~5 cm of filter gravel, on top of perforated, corrugated plastic 
sitting on the base of the tank.  Four air-riser pipes per tank ensured a circulation of water 
down through the sediment and up the air-riser in order to prevent anoxia of the sediment, 
reduce sediment resuspension, and lessen water turbidity.  Each mesocosm was supplied 
with ~100 L per hour of carbon-filtered 50% seawater (salinity = 17gL-1).   
Three bulk sediments were collected for use in the mesocosm experiments. Two 
contaminated sediments were obtained from dredged material from the estuary of the River 
Tyne, Riverside Quay, Jarrow, and also sediment collected by van Veen grab from the Firth 
of Forth, adjacent to the Grangemouth petrochemical complex. A clean reference sediment 
was manually collected from the estuary of the River Ythan, in North East Scotland, 
adjacent to the site of flounder collection. Each of the sediments was thoroughly mixed, and 
stored as large (~75 kg) aliquots that were held in plastic packing crates within a commercial 
frozen storage facility until required.   
Prior to introducing flounder to the tanks, the bulk Forth and Tyne sediments were 
combined (FT).  This sediment and the reference Ythan (Y) sediment were each thoroughly 
mixed (75:25) with filter sand, and aliquoted/stored as described above.  The filter sand was 
added to equalize the grain size of all sediments and to reduce the likelihood of the sediment 
becoming anoxic during the test. The final test sediments, ie mixed and with filter sand 
added, are hereafter referred to as ‘clean’ and ‘polluted’. 
The test sediments were added to duplicate tanks in May and benthic invertebrates 
were added 30 days later. After a further 30 days 60 0-group flounder (3.1±1.1 g, 56±6 mm) 
were added to each tank.  Benthic in situ invertebrate prey species were supplemented daily 
with frozen mysid shrimp (at a rate of ~1% of body weight/day) and once a week with 
commercial pellets (Bio-Optimal START 1.5mm, Biomar, 1% of body weight/week).  Water 
temperature and salinity were recorded weekly.  After three months, an additional 1-2 cm of 
test sediment was added to each mesocosm and the mesocosm-exposed fish were sampled 
after 7 months of exposure to the sediments.   
Five aliquots from each of the ‘clean’ and polluted’ sediments were collected for 
chemical analysis at the point of first addition to the tanks.   
Tanks were regularly inspected for mortalities and dead fish removed. After 7 
months, surviving fish were counted and taken for biometric, chemical and biological 
analyses. Salinity over the course of the experiment was 19.8±1.5‰ (mean of weekly 
measurements from each of the 4 tanks) and temperature was 12.3±2.7oC (mean of weekly 
measurements from each of the 4 tanks), ranging from a maximum of 16oC to a minimum of 
8oC, in accordance with the normal environmental variation over the period. 
 
2.3. Sediment chemistry 
 
Unless stated otherwise, chemical analyses were accredited to ISO/IEC 17025:2005 
by the UK Accreditation Service. 
 
2.3.1. Determination of sediment characteristics 
The particle size distributions of freeze dried test sediments were determined using a 
laser granulometer, after initial sieving to 2 mm.  The concentrations of Total, Inorganic, and 
Organic Carbon (TC, TIC, TOC) in freeze dried sediments, were determined using an 
elemental analyser.  Finely ground sediment samples were analysed either without 
acidification (TC), or following the addition of hydrochloric acid (TOC).  TIC was 
determined as the difference between the two. 
 
2.3.2. Determination of trace metal concentrations 
Freeze dried samples of test sediment were sieved (2 mm) and the fine material ball-
milled before being digested in a closed vessel microwave using concentrated nitric acid.  
Fish samples were homogenised and similarly digested.  Sample digests were diluted, 
internal standards added, and trace element concentrations determined by Inductively 
Coupled Plasma Mass Spectrometry (ICPMS).  Concentrations of Cr, Ni, Cu, Zn, As, Cd, 
Hg, and Pb were determined in sediments and flounder muscle and liver; additionally Mn, 
Co and Se were also determined in flounder muscle and liver. 
 
2.3.3. Determination of polycyclic aromatic hydrocarbons (PAHs) 
Hydrocarbons, including PAHs, were extracted from wet test sediment by sonication 
in dichloromethane and methanol, and from flounder muscle and liver by saponification.  
The extracts were purified and the PAHs separated from the aliphatic hydrocarbons using 
high performance liquid chromatography (HPLC).  Quantitative analysis of 40 two- to six-
ring (parent and branched) PAHs was carried out by gas chromatography with mass selective 
detection (GC-MSD, (Webster et al., 2009) (Webster et al., 2004). Results are presented as 
total naphthalenes (naphthalene + 1-methyl naphthalene + 2-methyl naphthalene + C2,C3,C4 
naphthalenes), total of the 40 PAH compounds, or as total benzo[a]pyrene-equivalent PAH 
concentrations (derived from the function of individual compound concentration and the 
Toxic Equivalency Factor (TEF), for the 16 PAH compounds for which TEFs are available. 
 
2.3.4. Determination of chlorinated biphenyls (CBs) and organochlorine pesticides (OCPs) 
CBs and OCPs were extracted from freeze dried sediments and dehydrated  samples 
by either soxhlet extraction using methyl-tert-butyl ether (MTBE) as the solvent or by 
Pressurised Liquid Extraction (PLE) using iso-hexane and with 5% deactivated alumina in 
the PLE cells as a fat retainer to partially clean-up the samples.  Concentrated extracts were 
further cleaned-up and OCPs and CBs separated with deactivated silica and the 
concentrations of 28 CB congeners and 20 OCPs determined by gas chromatography with 
electron capture detection (GC-ECD; (Webster et al., 2009)).  The determined OCPs were 
o,p' DDE, p,p' DDE, o,p' DDD, p,p' DDD, o,p' DDT, p,p' DDT, α-chlordene, γ-chlordene, 
oxychlordane, α-chlordane, γ-chlordane, total heptachlor, heptachlor epoxide, trans-
nonachlor, dieldrin, aldrin, endrin, α-HCH, γ-HCH, and hexachlorobenzene (HCB).  
Concentrations of individual CBs were determined and the reported results also included the 
total concentration of all the CBs monitored and the total of the “ICES7” CBs (sum of CBs 
28, 52, 101, 118, 138, 153 and 180).  Individual OCP concentrations were often below 
detection limits; data for those compounds most-often detected are presented (the sum of 
DDT and its metabolites, HCB) together with the sum of all OCP compounds.   
 
2.3.5. Determination of organotin compounds  
Freeze dried test sediment samples were sieved (2 mm) and the fine material ball-
milled before organotin compounds were extracted using acetic acid and methanol.  
Extracted organotins were derivatised using sodium tetraethylborate and the ethylated 
organotins simultaneously re-extracted into iso-hexane.  The iso-hexane extracts were 
cleaned-up with deactivated silica and the concentrations of ethylated di-, and tri-butyltin 
were determined by GC-MSD.   
 
2.3.6. Determination of polybrominated diphenylethers (PBDEs) 
PBDEs were extracted from freeze dried test sediments and dehydrated  samples by 
PLE using iso-hexane as solvent.  The concentrated extracts were cleaned-up and the 
concentrations of 17 (tri- to deca-brominated) PBDE congeners determined by GC-MSD 
(Webster et al., 2009).   
 
2.4. Hepatocyte preparation and treatment 
 
The overall experimental scheme is shown in Figure 1. Four male fish and two 
female flounder from each test group (‘clean’ and ‘polluted’) were selected randomly, by 
netting all fish into a holding tank and sampling the first four males and two females to be 
sub-sampled. These fish had lengths between 12 and 16.3cm. The skin of the fish was 
swabbed with 10% FAM disinfectant before removing livers. A sub-sample of each liver 
was frozen in liquid N2 for individual analyses. The remainder of each liver was finely 
chopped and hepatocytes prepared as described previously (Leaver et al., 2007). Following 
hepatocyte preparation washed cell pellets were resuspended in 10ml of DMEM, 10%FBS, 
PSK and cell concentration determined in each preparation using a hemocytometer. Two 
pools were then made containing equal numbers of cells originating from each of the six 
flounder from each ‘clean’ or ‘polluted’ group. These pools were then distributed to six-well 
polystyrene culture  
 
dishes to provide 106 cells in 2ml in each well.  Culture dishes were incubated for 2 hours at 
12˚C, 4% CO2 before adding 5µl of DMSO or 5µl DMSO containing 20mM benzo(a)pyrene 
(BAP), 0.4mM estradiol (E2) or 4mM copper sulphate (Cu), to give final exposure 
concentrations of 50µM BAP, 1µM E2 and 10µM Cu. Hepatocytes were also treated with a 
mixture of all three compounds (MIX), each at the concentrations stated above. All 
treatments were performed as six replicates. After 40 hours of exposure at 12˚C, 4% CO2, 
three replicates of each treatment were harvested by aspiration and cells pelleted at 1000g for 
3 mins. Cell pellets were immediately resuspended with vigorous vortex mixing in 200µl of 
RNA extraction solution (TriReagent, Sigma). Cells in the remaining culture dish wells were 
assessed for viability by counting number of cells excluding Trypan Blue using a 
hemocytometer and microscope. Viability was between 72 and 81% in all treatments after 40 
hours and did not significantly vary between treatments.  
 
2.5. Microarray Hybridisation 
 
Total RNA was prepared from pooled hepatocyte cell pellets using TriReagent RNA 
extraction buffer (Sigma) according to the manufacturers protocol. Each hepatocyte 
treatment consisted of three experimental replicates for microarray hybridisation. Total RNA 
from individual livers was prepared by homogenising liver fragments in 8 ml/g methanol, 
2.5ml/g water. One hundred microlitres of the aqueous phase was then processed for RNA 
purification using binding to/elution from an anion exchange mini-column (RNeasy Midi 
Kit, Qiagen). Final RNA concentrations were measured using a Nanodrop 
spectrophotometer and integrity checked by assessing the relative proportions of 28S and 
18S RNA using agarose gel electrophoresis. All samples showed approximately 2 fold more 
ethidium bromide staining in 28S band than in 18S band, indicating that the samples were  
not significantly degraded. 
 
 
Figure 1. Schematic of experimental design and procedures. 
 
Five hundred nanograms of each total RNA sample was amplified using a 
commercial amplification and amino-allyl labelling kit (Amino Allyl MessageAmp II aRNA 
Amplification kit, Ambion). Amplified RNA yield was quantified using a Nanodrop 
spectrophotometer and 20µg was incubated with mono reactive NHS ester Cy3 dye (GE 
Healthcare). Labelled, amplified RNA probe was purified according to commercial kit 
instructions. A pool containing equal amounts of total RNA from each sample was labelled 
with Cy5 dye using the same method. Yields of labelled, amplified RNAs were quantified 
using a Nanodrop spectrophotometer.  
The construction and validation of the GENIPOL European flounder 16K cDNA 
microarray used here has been described in detail previously (Williams et al., 2006) (Diab et 
al., 2008). The array consisted of 27648 elements, which, after contig clustering, resolve into 
3336 genes. The array design with accession numbers is available through EMBL 
ArrayExpress, accession number A-MAXD-12 (http://www.ebi.ac.uk/microarray 
as/aer/lob?name=adss&id=1308203622). A universal pooled reference design was used to 
plan microarray hybridisations (Fig1). Thus, each slide received 80pmol of Cy3 labelled, 
amplified RNA and 80pmol of Cy5 labelled pooled reference amplified RNA. Hybridisation 
procedures and solutions have been described previously (Williams et al., 2006). 
 
Table 1. Primers and gene IDs used for QPCR. 
 
Gene Forward (5’-3’) Reverse (5’-3’) GenBank 
β-actin GACCAACTGGGATGACATGG GCGTACAGGGACAGCACAGC AF135499 
α-tubulin CACAGCCTCACTTCGTTTTG AGATGACAGGGGCATAGGTG AJ291985 
Ef1A GTTGAGCGCAAGGAGGCTAA CGAGCATACCGGGCTTAATG EC378684 
Cyp1A CAACCATGATCCAGAGCTGTG GATTATTCTTCCTCCACTGACTCT AJ132353 
UGT1B CCTTCCCGCAGAGAGTCATA AGAGAGCCCCATGACTGAGA AM746199 
Vitellogenin CTGACCTTCGTGGATATTGAG ATCTGAGCCTCGGCATTG AJ416327 
Metallothionein CTTGCGAATGCTCCAAGACTG TGGTGTCGCATGTCTTCCCT DV565672 
Glutathione 
reductase GGCTTCTTGCGTGAATGTTGG CGAGGTTGCTACGATAAATGCG AJ578037 
Hepcidin TCACCAGCAGAGTCAAAGAACT ATGCTCAGCAGCTGCATTGT DV569429 
Diablo CCTCATTCGAGGAGGATTCG ACTGGGCCACCTGAATGTTT EC377887 
Transthyretin ACTCCGAGCTGATGATTTGG CCAAGACCCTCCCAGTATGA DV566569 
Complement C9 GCTCATGCCCTCAAACAGGT GTTGGACATGCCTGGTGCTA DV569533 
Glutathione S-
transferase A TCACGCTCACCCAGAAAATG GAAAACCGACACATCAGCCA DV567811 
CuZn superoxide 
dismutase TGGAGACAACACAAACGGG CATTGAGGGTGAGCATCTTG AJ291980  
 
Following hybridisation, microarray slides were washed, dried and scanned with a 
Perkin Elmer ScanArray Express microarray slide scanner. Scanned images were first 
analysed by Bluefuse software (BlueGnome Ltd, UK) which was used to identify features, 
fuse replicates and quantify Cy3 and Cy5 fluorescent signals from each feature. Bluefuse 
data was then analysed in Genespring GX7.3.1. (Agilent). To normalise data, all features 
with less than 0.01 fluorescence units were first discarded, then a Lowess per spot, per chip 
normalisation was carried out. Features whose sequence data formed contigs (Williams et 
al., 2006) were treated as on-chip replicates in Genespring. 
The entire data set was first analysed by 2 Way ANOVA, implemented in 
Genespring, using Sediment (‘clean’ and ‘polluted’) and Treatment (BAP, EST, CU and 
MIX) as factors. This provided a list of features whose expression was significantly (with 
Bonferroni and Hochberg False Discovery Rate correction, FDR p<0.05) dependent on 
sediment, on treatment, or which exhibited interaction between sediment and treatment. To 
identify features which were changed by individual treatments or which showed interaction 
with individual treatment and sediment, the 2 way ANOVA output list were filtered first by 
pairwise t-tests (p<0.05) and second by 2 fold up- or down-expression. 
The probability that a particular biological process GO term was enriched in an 
output GO list (all GO annotations associated with the experimentally altered gene list) 
compared to the input GO list (All GO annotations associated with the array)  was calculated 
using a hypergeometric distribution model as implemented by GeneSpring GX 7.3.1. The 
GO annotation of the flounder microarray has been described (Williams et al., 2006). 
MIAME-compliant microarray data (Brazma et al., 2001) were submitted to 
ArrayExpress at EMBL-EBI (http://www.ebi.ac.uk/microarray-as/ae/) using MaxdLoad2 
software (Hancock et al., 2005) and have been assigned accession number E-MAXD-55. 
 
2.6. Quantitative real time PCR (QPCR) 
 
QPCR was performed using the treated hepatocyte RNA extracts, or using RNA from 
the individual hepatocyte source fish. Complementary DNA (cDNA) was synthesized from 
total RNA using a commercially available kit according the manufacturers instructions 
(Reverse-iT Max 1st strand synthesis kit, ABgene). Briefly each reaction of 20µL contained 
1.0µg of total RNA, 300ng of random hexamers and 125ng of anchored oligo-dT.  Following 
cDNA synthesis at 42˚C for 1 hour reactions were stopped by heating at 75˚C for 10 min and 
cDNA diluted to 500µL total volume with water. QPCR was performed using a Quantica 
machine (Techne). QPCR analysis for each gene was performed in triplicate in a total 
volume of 20µL containing 5 µL cDNA (equivalent to 10ng of input RNA), 100nM of each 
primer and 10 µL of Absolute QPCR SYBR Green Mix 2X (ABgene). For each of target 
genes, forward and reverse primers were chosen from the available EST sequences by using 
Primer-BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast/). Target genes were 
selected by consideration of microarray data and by BLAST comparison of flounder ESTs 
deposited in Genbank with sequences of mammalian and other fish genes of interest. Primer 
pairs and EST information are provided in Table 1. Thermal cycling was initiated with 
incubation at 95°C for 15 min in order to activate the DNA polymerase present in the mix. 
After this initial step, forty-five cycles of PCR were performed. Each PCR cycle consisted of  
heating for 15 s at 95°C for denaturing, and then for 15 s at 60°C and 30 s at 72°C for 
annealing and extension. Cycle threshold (CT) values corresponded to the number of cycles 
at which the fluorescence emission monitored in real time exceeded the threshold limit. 
Melting curve analysis was performed to indicate the production of a single product 
in these reactions. Standard curves were established for each gene by plotting CT values 
against the log10 of five different dilutions (in triplicate) of cDNA sample solutions. In 
addition a subset of randomly selected samples generated by each primer pair was analysed 
by agarose gel electrophoresis and sequencing to confirm the identity of amplicons. Real-
time efficiency was determined for each gene from the slopes given by Quantsoft (Techne) 
software, applying the equation E=10(-1/slope). The calculated relative expression ratio of each 
gene was based on the PCR efficiency (E) and CT of sample compared with control, and 
expressed in comparison to the reference genes, β-actin, α-tubulin and ef1A.  These genes 
were not changed in any of the treatments, as observed after microarray analysis. 
Statistically significant differences in gene expression between the ‘clean’ vehicle (DMSO) 
treated hepatocytes or fish and all other possible treatment X sediment conditions were 
evaluated in group means by randomization tests (Pfaffl et al., 2002) using REST© software. 
Five thousand random allocations were applied and differences were considered to be 
significant at P≤0.05. 
 
3. Results 
 
3.1. Flounder Biometry 
 
Forty eight fish in the ‘clean’ mesocosms (40% mortality rate) and twenty-nine fish 
in the ‘polluted’ mesocosms (24% mortality) died during the experiment.  Chi-squared 
analysis indicated that mortality of fish on the “clean” sediment was higher than expected 
(24%) and mortality of fish on the “polluted” sediment was lower than expected (Fisher’s 
exact χ2 test, p=0.012).  There was a tank effect (Pearson χ2 test, p<0.001); whilst tank 1 
(‘clean’; 20% mortality) and tank 4 (‘polluted’; 45%) had mortalities not significantly 
different to those expected (32%), mortalities in tank 3 (‘clean’; 60% mortality) were higher 
than expected and in tank 2 (‘polluted’; 3.3%) were lower than expected.   
In the 7 months between introduction to the mesocosm and sampling, the flounder 
grew in length and weight, although they were in poorer condition (based on comparison of 
body wt / L3  x 100, not shown). There were no treatment-related differences between length, 
weight, or condition (not shown). All were classed as unsexed when introduced, and there 
were no significant variations from the expected sex 50:50 ratio for either treatment after 7 
months. There were no significant treatment-related differences (t-tests) in the 
gonadosomatic index (GSI; gonad weight / total weight x 100) of fish classed as either male 
or female after 7 months (not shown). There were no external signs of disease (fin rot, skin 
lesions or abnormal pigmentation) in fish after 7 months from either treatment.  
 
3.2. Sediment chemistry 
 
The contaminant profiles of each sediment are presented in Table 2. Several different 
priority chemical pollutants were measured in order to establish the extent to which the 
contaminated mesocosm represented a typical multiply-polluted estuarine sediment. Despite 
mixing filter sand with both Tyne/Forth and Ythan sediments, there was still a significant 
difference in grain size distribution between the final ‘clean’ and ‘polluted’ test sediments in 
the mesocosms. A difference in total organic carbon (TOC) content between the two 
sediments was also apparent and therefore results for organic and metal contaminants are 
presented as absolute values, and as values normalised to either TOC or grain size. 
Irrespective of normalisation, the ‘polluted’ mesocosm sediment showed significantly higher 
values for most contaminants than the ‘clean’ sediment. The exception was that the ‘clean’ 
sediment was more contaminated with “Total OCPs” than the ‘polluted’ sediment, and that 
normalised concentrations of Cd and some PAHs (total “NOAA n=14 PAH” were not 
significantly different between the two sediments. PAH ratios (not shown) indicated that the 
PAH contamination of both sediments was predominantly pyrolytic in origin (Webster et al., 
2004).  
In several cases sediment contaminant concentrations exceeded environmental 
quality standards. OSPAR Background Assessment Concentrations (BACs; (OSPAR, 2008)) 
were exceeded in both sediments for several PAHs (naphthalene, phenanthrene, anthracene, 
fluoranthene, pyrene, benz[a]anthracene, chrysene and benzo[a]pyrene) and five CB 
congeners, whilst the concentrations of two further CBs and the PAH benzoperylene also 
exceeded the BAC in the ‘polluted’sediment.  CB concentrations did not exceed OSPAR 
Environmental Assessment Criteria (EACs; (OSPAR, 2008)) in either sediment. Similarly, 
the ‘clean’ sediment did not exceed the NOAA Effects Range Low (ERL; (NOAA, 1999)) 
for any compounds; however, the ‘polluted’ sediment exceeded the NOAA ERLs for 
ΣDDTs, naphthalene, phenanthrene, As, Hg, Ni, and Pb. A single sample of sediment was 
taken from each tank when the fish were removed. Clean and polluted sediments were each 
pooled and analysed to provide a single measurement of PAH and CB in each sediment 8 
months after setting up the mesocosms. There was no apparent decrease in total PAHs or 
total CBs; the measured levels fell within the 95% confidence intervals for the initials 
measurements. 
 
 
Table 2. Summarised absolute and normalised contaminant concentration data. 
 
ABSOLUTE NORMALIZED 
Ythan Forth/Tyne  Ythan Forth/Tyne 
 
Mean SD Mean SD  Mean SD Mean SD 
%<20 µm 10.5 0.74 25.2 0.70  
Grain size 
%<63 µm 44.6 1.29 54.4 0.77  
Carbon %TOC 1.15 0.21 2.77 0.26  
Metals normalised to grain size 
Organics normalised to carbon 
DDT & metabolites 1.09 0.19 1.72 0.48  2.39 0.20 1.57 0.52 
HCB 0.18 0.003 1.33 0.06  0.40 0.07 1.21 0.16 OCPs 
TOTAL OCPs 2.25 0.19 4.07 0.53  4.97 0.51 3.71 0.73 
ICES 7 CBs 1.21 0.24 4.43 0.71  2.67 0.66 4.06 1.00 CBs 
TOTAL CBs 1.56 0.45 8.95 1.81  3.52 1.34 8.22 2.36 
Naphthalenes 103 29 2080 718  228 37 1903 757 
NOAA (n=14) PAH 372 59 1527 531  792 143 1300 520 
TOTAL PAH 1104 209 7267 2402  2444 505 6649 2626 PAH 
B[a]P-eq PAH 59 9 174 65  129 17 159 68 
Tributyltin <6 - 48.8 8.8  <4.5 - 89.7 16.0 Organotins 
 Dibutyltin <6 - 9.2 0.6  <2.9 - 16.9 1.1 
As 4.00 0.18 9.09 0.18  8.98 0.51 16.7 0.16 
Cd <0.24  0.201 0.075  <0.27  0.37 0.13 
Cr 21.5 0.7 33.8 2.5  48.2 1.80 62.1 4.57 
Cu 7.50 0.32 24.1 1.5  16.8 0.81 44.2 2.20 
Hg <0.063 - 0.310 0.024  <0.07 - 0.57 0.05 
Ni 14.0 0.5 21.4 0.5  31.4 1.38 39.4 0.67 
Pb 11.7 0.3 51.4 1.5  26.1 0.87 94.4 3.19 
Metals 
(mg/kg) 
 
Zn 39.8 1.1 98.1 1.2  89.3 3.36 180.2 1.87  
 
Data is mean and SD of five replicate subsamples for each of the two test sediments  (clean, Ythan and 
polluted, Forth/Tyne) prior to addition to the mesocosm aquaria (µg/kg dry wt, unless indicated otherwise). 
Normalised to a TOC content of 2.5% (for organic contaminants) or to a sediment grain size of 100% <63 µm 
(metals and organotins). “Less than” values indicate results below analytical detection limits.  TOC = total 
organic carbon; OCP = Organochlorine pesticides (HCB = hexachlorobenzene; total = sum concentration of 20 
different compounds, see methods section); CBs = chlorinated biphenyls (see methods);  PAH = polycyclic 
aromatic hydrocarbons (NOAA compounds = sum of those PAH compounds for which NOAA Sediment 
Quality Guideline ER values are available (see Table 1); total = sum of 33 PAH compounds; B[a]P-equivalent 
concentration based upon the toxic equivalency factors for the “USEPA 16” (USEPA, 1993), see methods for 
details).  Tyne/Forth concentrations are boldened and underlined where they are significantly different (p<0.05) 
from Ythan concentrations.  “NOAA” = US National Oceanic and Atmospheric Administration. 
 
3.3. Comparison of individual fish livers with hepatocyte pools 
 
To determine whether the levels of gene expression in the hepatocyte pools were 
representative of gene expression in the populations of fish exposed to each type of 
sediment, the expression of selected genes which showed differences in microarray analysis 
were tested. Thus, quantitative rtPCR (QPCR) measurement of the expression levels of five 
genes which were changed in hepatocytes from fish from ‘polluted’ sediment compared to 
those from ‘clean’ sediment, showed that these genes were also changed in the same 
direction and by similar amounts when measured in each of the individual source fish from 
which the hepatocytes were prepared (Fig2). 
 
  
Figure 2. QPCR determination of gene 
expression in pooled hepatocytes and individual 
hepatocyte source fish. 
The open bars represent the expression level of 
selected mRNAs in hepatocytes (n=3 replicate 
pools) from fish exposed to 'polluted' sediments 
relative to expression in  hepatocytes (n=3 
replicate pools) from fish exposed to ‘clean’ 
sediment. Closed bares represent the expression 
level of the selected mRNAs in individual flounder 
(n=6) from 'polluted' mesocosms relative to 
flounder (n=6) from 'clean' mesocosms. Error bars 
represent standard deviations of the mean and 
asterisks indicate a significant difference (p<0.05, 
REST 2008) from the controls groups. 
 
3.4. Genes affected by sediment exposure or treatment 
  
Initially an overall exploratory analysis of all the genes affected in hepatocytes was 
conducted by first applying 2-way ANOVA to generate a list of significantly changed genes 
in any treatment or sediment group. This list was then analysed by clustering methods, to 
search for parameters which may be predictive of gene expression or  of treatment. Thus, 
application of 2-way ANOVA, with false discovery rate correction (FDR p<0.05), to 
compare all combined treatments (DMSO, BAP, CU, E2 or MIX) with sediment (‘clean’ or 
‘polluted’) returned a list genes which were significantly changed by sediment, by treatment 
or by both factors. Nine hundred and seventy eight of these genes were associated with 
sediment, 951 with treatment and 206 showed interaction between sediment and treatment. 
Hierarchical clustering (Fig 3) of all of these significantly altered genes based on 
experimental condition, showed that neither sediment origin, nor subsequent acute treatment 
could predict the gene expression profile. Thus, vehicle-treated hepatocytes from fish from 
the ‘clean’ sediment mesocosms clustered separately from all other groups, whilst Cu and E2 
treated hepatocytes clustered according to sediment type rather than treatment. There was 
some indication that BAP and MIX treatments clustered together, irrespective of sediment 
type. Clustering by gene was performed hierarchically and by supervised K-means clustering 
for five groups. These two methods produced similar clusters (Fig 3), and examination of the 
K-means clusters in more detail indicated that the majority of genes in four of the groups 
could be interpreted as: increased by polluted sediment (Group 2); decreased by polluted 
sediment (Group 3); increased by BAP or MIX (Group 1); decreased by BAP or MIX 
(Group 4). The fifth group did not correspond to any particular treatment, but contained the 
majority of genes which were present in the interaction group output from the initial 2-way 
ANOVA test. 
Further filtering of the gene list associated with sediment was performed to generate 
a final output list. The filtering process first eliminated genes from the total sediment 2 way 
ANOVA output, which showed a p value of ≤0.05 after a comparison of ‘clean’ DMSO-
treated hepatocytes with ‘polluted’ DMSO-treated hepatocytes. Secondly, the T-test output 
list was filtered to exclude genes which were less than 2 fold up or down-regulated after 
comparing ‘clean’ DMSO-treated with ‘polluted’ DMSO-treated. This resulted in a final 
output list of 57 genes whose expression was considered to be changed by exposure to 
polluted sediment (Table 3). The biological process GO terms associated with these genes 
were compared with the total GO list for the microarray, and tested for significant (p≤0.05) 
over-representation as implemented in GeneSpring GX 7.3.1 (Agilent). Only GO categories 
represented by more than one gene from the final gene list were considered significant and 
are reported in Table 4. Genes whose expression changed after each treatment (BAP, CU, E2 
or MIX) were defined by the same methods. First the total 2-way ANOVA output list which 
was associated with treatment was filtered by T-test p-value using comparisons between 
BAP, CU, E2 and MIX treated hepatocytes, each with DMSO-treated hepatocytes. Second 
each of these output lists were filtered by 2-fold up or down in expression level 
(Supplementary Tables 1-4) 
 
 
 
Figure 3. Clustering of 2-way ANOVA hepatocyte output list by condition and by gene. 
All genes from hepatocytes which were changed according to 2-way ANOVA (Sediment X Treatment, p<0.05, 
FDR correction) were clustered heirarchically by condition (Y-CON, Ythan, untreated; Y-BAP, Ythan, 
benzo(a)pyrene treated; Y-E2, Ythan, estradiol treated, Y-CU, Ythan copper sulphate treated; Y-MIX, Ythan 
BAP+E2+Cu treated; FT-CON, Forth/Tyne, untreated; FT-BAP, Forth/Tyne, benzo(a)pyrene treated; FT-E2, 
Forth/Tyne, estradiol treated, FT-CU, Forth/Tyne copper sulphate treated; FT-MIX, Forth/Tyne BAP+E2+Cu 
treated ) and by gene (not annotated). The relative expression levels of the genes are indicated in heat map 
form, with red representing high and blue, low. Genes were also clustered using K-means supervised for 5 
groups. Genes from the five K-means clusters are mapped onto the hierarchical gene tree using colours. The 
similarly coloured bars to the right of the heat map correspond to congruent clusters of genes produced by K-
means and hierarchical methods. The numbers of genes in each cluster which belong to Sediment, Treatment or 
Interaction between sediment and treatment groups from 2-way ANOVA are indicated using Venn diagrams. 
 
 
Table 3. Genes whose expression changed in pooled hepatocytes from fish exposed to ‘polluted’ sediments compared 
to hepatocytes from fish exposed to ‘clean’ sediments. 
 
 
Derived by determining which genes from 2-way ANOVA output list “sediment genes” were significantly 
changed (T-test p<0.05 and >2-fold up or down as indicated in table) in vehicle-treated ‘polluted’ pooled 
hepatocytes versus vehicle-treated ‘clean’ pooled hepatocytes (T-test, p <0.05, indicated in table). Clone is 
contig name and GenBank ID gives a representative accession number for the contig. Blast hit is best match of 
contig sequence to non-redundant protein database by BLASTX (maximum e value 1.0e-6). 
 
 
Clone Fold p-Value Blast Hit GenBank ID 
APOPTOSIS     
Contig122 2.449 0.00938 Diablo DV566149 
PfIL279C03 3.073 0.0141 Diablo homolog DV568917 
Contig265 2.171 0.00313 similar direct IAP binding protein with low PI aj580508 
PfIL227E10 2.563 0.00462 similar direct IAP binding protein with low PI DV566712 
PfIL273F12 2.146 0.0434 deoxyribonuclease II, lysosomal EC378848 
IMMUNE     
Contig439 4.64 3.12E-05 Hepcidin precursor DV566834 
Contig468 2.409 0.000314 hepcidin precursor aj578016 
PfIL201C01 2.411 0.0305 hepcidin precursor DV565788 
PfIL201H05 0.48 0.00143 interleukin 8 DV565814 
Contig59 2.049 0.00277 interleukin 8 precursor DV565292 
Contig812 0.464 0.0077 interleukin-8 variant DV565810 
PfIL020F12 2.401 0.00012 similar to small inducible cytokine B6 DV565696 
PfFMO2-ll0 2.891 0.00375 inter-alpha-trypsin inhibitor heavy chain 2 aj310420 
Contig533 2.473 0.0125 complement component C9 DV565432 
PfIL008C04 3.012 0.0392 complement component C9 DV565523 
PfIL292H03 2.215 0.000754 C-type lectin 2-1 (poor seq) na 
(likely C-type lectin 2.1) 2.082 0.000823 (likely C-type lectin 2.1) na 
PfIL228H02 2.018 0.0157 integrin beta 1 isoform 1A precursor DV566763 
Contig413 2.176 0.000753 MASP protease / haptoglobin DV566657 
Contig146 2.117 0.000898 Phospholipase A2 DV566640 
PfIL223G08 2.476 0.00528 similar to transthyretin (4L369) DV566569 
DETOXIFICATION    
PfPARA-o2 2.272 0.00881 Paraoxonase 2 aj292086 
PfIL210E01 2.548 0.0188 hydroxyacid oxidase 1 DV566184 
AA METABOLISM     
Contig483 2.157 0.00243 betaine-homocysteine methyltransferase DV567657 
PfIL218B01 2.568 0.000927 betaine-homocysteine methyltransferase  DV566389 
MEMBRANE TRAFFICKING    
PfIL001B04 2.125 0.0005 Reticulon-1 DV565298 
RNA PROCESS    
PfPARP-l1 2.194 0.00999 RNA binding motif protein 25 aj310714 
GROWTH     
PfIL244E12 2.691 0.00199 Insulin-like growth factor IA precursor (IGF-IA) DV567425 
PROTEOLYSIS    
Contig685 0.49 4.03E-05 High choriolytic enzyme 1 precursor DV567267 
ENERGY GENERATION    
PfIL298D09 0.494 0.000176 NADH dehydrogenase subunit 2 DV569603 
NUCLEAR TRANSPORT    
PfIL249C07 0.392 0.0023 nucleoporin 214kDa DV567616 
OXYGEN TRANSPORT    
PfIL288E08 0.4 0.000476 alpha-type globin EC379099 
RIBOSOME     
PfIL214A05 0.407 0.00235 18S ribosomal RNA DV566284 
PfIL230E06 2.107 0.0311 18S ribosomal RNA (poor seq) na 
PfIL209H10 2.325 0.00476 18S rRNA gene EC377855 
PfIL217F03 0.46 0.031 60S ribosomal protein L10a EC377989 
Table 4. Over-represented biological process GO categories in pooled hepatocytes from fish exposed to 
‘polluted’ sediments compared to hepatocytes from fish exposed to ‘clean’ sediments. 
 
Category In Background In List p-Value 
GO:6955: immune response 113 10 2.78E-05 
  GO:6959: humoral immune response 30 3 0.0193 
    GO:6956: complement activation 23 3 0.00925 
    
GO:8219: cell death 91 5 0.0291 
  GO:6917: induction of apoptosis 20 3 0.0062 
     GO:43065: positive regulation of apoptosis 22 3 0.00815 
     GO:6919: caspase activation 9 3 0.000528 
        GO:8635: caspase activation via cytochrome c 4 2 0.00218 
  GO:19835: cytolysis 12 2 0.0217 
    
GO:42221: response to chemical stimulus 115 7 0.00537 
   GO:9410: response to xenobiotic stimulus 34 4 0.0037 
     GO:6805: xenobiotic metabolism 34 4 0.0037 
   GO:6935: chemotaxis 23 3 0.00925 
 
’In Background’, the number of genes present in the indicated GO category present on the total microarray. ‘In 
List’, the number of genes in the indicated GO category present in the output list (polluted versus clean 
sediment). The p-Value indicates the probability that the GO category is over-represented in the output list 
compared to the background list. 
 
From these microarray output lists it is apparent that BAP and E2 have the expected 
inducing effects on, for example induction of CYP1A and vitellogenin mRNA respectively. 
These effects were confirmed by QPCR (Fig 4), along with measurements on other genes 
which were associated with sediment type (Diablo, transthyretin, hepcidin) and genes which 
are regularly reported in biomarker studies (UGT1B1, CuZnSOD, glutathone reductase, 
GSTA) Together these measurements demonstrate that ‘clean’ and ‘polluted’ hepatocytes 
respond similarly, although not identically when treated with the BAP or E2 or Cu. Thus, 
although BAP treatment caused large increases in both CYP1A and UGT1B, both previously 
shown to be responsive to BAP in flounder (Leaver et al., 2007), it is apparent that BAP and 
Cu also increased vitellogenin mRNA levels in ‘clean’ hepatocyes, but not in ‘polluted’ 
hepatocytes. Co-administration of BAP, E2 and Cu caused a similar level of increase in 
CYP1A and UGT1B as BAP alone, but levels of vitellogenin mRNA were much reduced in 
comparison to levels seen with E2 alone. Also apparent is that both UGT1B1, glutathione 
reductase and glutathione S-transeferase show a very similar treatment-response profile to 
that of CYP1A. Furthermore the responses of Diablo and transthyretin, which were 
associated with sediment treatment in microarray analysis are also associated with sediment 
in QPCR profile, being higher in all polluted sediment hepatocytes than in clean, irrespective 
of subsequent acute treatment. 
 
4. Discussion 
 
The experiment described here was designed to discover how flounder are affected 
after relatively long-term association with multiply polluted estuarine sediments. This was 
achieved by categorising genes in flounder whose expression was changed in response to 
chronic exposure for 7 months to contaminated sediment. In order to reduce the variability 
which may be associated with site-specific parameters such as salinity, temperature, or 
feeding behaviour, or to avoid effects of genetic differences between flounder populations, 
the experiment was conducted in mesocosms using a single population of flounders taken 
from a “clean” site, the Ythan estuary. These fish were then exposed to a sediment derived 
from their native Ythan estuary, or a mixture of sediments taken from two contaminated sites 
in the UK, the Tyne and Forth estuaries. After 7 months of exposure there were no 
differences in sex ratios or condition indexes between fish from the ‘clean’ and ‘polluted’ 
tanks. There was evidence of a tank-related difference in mortality rate. One of the ‘clean 
replicate mesocosms had an unusually high mortality rate and one of the ‘polluted 
mesocosms, an unusually low rate. Such variability in survival in mesocosms, either for 
flounder, (Vethaak et al., 1996) or more generally for many organisms has been observed 
before. Whilst this variability is a problem for the assessment of effects on community 
structure and other higher level ecosystem variables, inter-individual variation in organisms, 
within or between groups is much lower (Caquet et al., 2000). Furthermore, since the higher 
mortality occurred in one of the clean mesocosms, it is clear that the pollutant status of the 
sediments is unlikely to be the cause.  
 
 
Figure 4. QPCR determination of mRNA levels for selected genes in pooled hepatocytes 
Expression level in treated hepatocytes is represented relative to expression in pooled hepatocytes from fish 
exposed to ‘clean’ (Ythan) sediment. Error bars represent lower bound standard deviations of the mean and 
asterisks indicate a significant difference (p<0.05, REST 2008) from the ‘clean’ group. Genes measured are 
CYP1A, cytochrome P4501A;, UGT1B, UGT-glucuronosyltarnsferase 1B; GR, glutathione reductase; GSTA, 
glutathione S-transferase A; Vitello, vitellogenin; CuZnSOD, coper-zinc-superoxide dismutase. Treatments are: 
Y-BAP, Ythan, benzo(a)pyrene treated; Y-E2, Ythan, estradiol treated, Y-CU, Ythan copper sulphate treated; 
Y-MIX, Ythan BAP+E2+Cu treated; FT-CON, Forth/Tyne, untreated; FT-BAP, Forth/Tyne, benzo(a)pyrene 
treated; FT-E2, Forth/Tyne, estradiol treated, FT-CU, Forth/Tyne copper sulphate treated; FT-MIX, Forth/Tyne 
BAP+E2+Cu treated. To aid clarity the open bars represent measurements made in hepatocytes for fish exposed 
to the clean Ythan (Y) sediment and shaded bars to measurements made in hepatocytes from the polluted 
Forth/Tyne (FT) sediment. 
 
Chemical analysis of the sediments indicated that the ‘polluted’ test sediment 
contained significantly higher levels of a range of contaminants than the ‘clean’ sediment 
and were higher than recognised background concentrations. In several cases contaminant 
concentrations exceeded internationally recognised environmental quality thresholds, 
indicating a potential to cause biological effects in exposed organisms. We interpret these 
results as strong evidence that the mesocosms accurately reflected the natural situation of 
long-term, chronic contaminant exposure that flounder would be subject to in a typical 
industrialized, Northern temperate estuary. Despite the clear elevation of contaminant levels 
in the polluted sediment, there was only limited evidence of an increase in flounder tissue 
contaminant levels after 7 months of exposure. Of the metals only lead showed a significant 
elevation in flounder muscle tissue and none of the organic contaminants showed elevations 
(not shown). However, there was a significant elevation in bile 3-hydroxypyrene in fish from 
the ‘polluted’ mesocosms (not shown), indicating that although PAHs were not 
accumulating, they were being taken up, metabolised and excreted to a greater extent than in 
fish maintained on the ‘clean’ sediment. 
In order to compensate for the natural variability in gene expression amongst 
individual flounder we analysed the transcriptome in pooled hepatocytes derived from 
multiple fish exposed either to polluted or to clean sediment. In addition, hepatocytes were 
further treated with prototypical environmental pollutants. This provided a means to directly 
compare chronic and acute chemical effects in hepatocytes from fish exposed to clean or 
polluted sediments.  
Validation of the transcriptomic results consisted of a pre- and post microarray 
analysis. The pre-microarray analysis consisted of QPCR measurement of a representative 
selection of genes in the original 6 fish from ‘clean’ and 6 fish from ‘polluted’ sediment. The 
purpose of this test was to determine whether the expression levels of these genes in the 
individuals used to make the hepatocyte pools were representative of populations of fish 
exposed to each type of sediment, in turn indicating the validity of the pooling process. Five 
genes whose mRNA levels were increased in pooled hepatocytes from fish exposed to 
polluted sediments were selected. If these genes were also statistically significantly elevated 
in the individuals from which the pooled hepatocytes were derived, then the pooling 
procedure is experimentally valid. The results of this analysis demonstrated good agreement 
between the pooled hepatocytes and the individual source fish. There were no ‘outliers’ in 
the individual source fish and it was possible to show statistical significance of differences in 
gene expression, similar to hepatocyte replicates. We thus conclude that the gene expression 
measured in pooled hepatocytes was a reasonable representation of the hepatic gene 
expression population means of the fish in the mesocosms. 
After clustering all changed genes and conditions by unsupervised hierarchical 
method or by a supervised clustering method, it was apparent that sediment of origin had a 
large effect on gene expression, irrespective of subsequent acute treatment. Treatment with 
Cu or E2 had little effect on overall gene expression compared to sediment of origin. In 
contrast, treatment of hepatocytes with BAP or MIX did have large effects. This overview of 
gene expression indicates that exposure to the multiply-polluted sediment caused clear 
changes in gene expression, and that the effects of acute exposures to single chemicals were 
in some cases small in comparison (Cu and E2), and in other cases clearly different (BAP 
and MIX), showing one reason why it has been difficult to associate acute laboratory-
derived transcriptomic profiles with field-derived profiles. 
To derive more biological meaning from global profiles, the list of genes changed by 
sediment after 2 Way ANOVA was categorized by filtering using pairwise T-tests and fold 
expression in ‘polluted’ versus ‘clean’ sediment hepatocytes. Several over-represented gene 
ontology categories could be derived from this list. These included; immune response, 
particularly complement activation; apoptotic induction and caspase activation and 
xenobiotic metabolism. Consideration of the individual genes making up these GO 
categories, along with other genes on the output list which were not annotated, indicates that 
a large proportion of the contribution to the immune response and a number of other genes 
could also be classified as acute phase reactants (Heinrich et al., 1990). Although it is not 
possible to predict the effect of these liver gene expression changes on blood protein levels, 
the level of increase (2 to 3 fold) of acute phase reactant mRNA expression is indicative of 
low grade inflammation, typically caused by low level chronic infection, metabolic 
dysfunction, or chemical exposure (Forrester and Bick-Forrester, 2005) (Mullenix et al., 
2005) (Yudkin et al., 2000). It is also notable that this list of genes changed by exposure to 
polluted sediment does not include typical biomarker genes. To further investigate, CYP1A, 
a gene which characteristically increases in expression following acute exposure to PAH, 
dioxin and planar CBs, and is thus a very widely used exposure biomarker (van der Oost et 
al., 2003) was measured by QPCR in both the hepatocytes and in the individual source fish. 
Contrary to expectation, CYP1A mRNA was decreased in flounder exposed to ‘polluted’ 
sediments for 6 months. Many studies have reported increases in CYP1A in flounder 
exposed to contaminated sediments (van der Oost et al., 2003). However, other studies on 
the effects of chronic exposure to multiply-polluted sediments have also reported a lack of 
expected response by hepatic CYP1A in flounder and in other species (Eggens et al., 1996) 
(Reynolds et al., 2003). Notably, despite a lack of CYP1A response, flounder held long-term 
in mesocosms containing contaminated sediment did exhibit an increased incidence of 
hepatic lesions (Vethaak et al., 1996). In the experiment reported here there was no 
indication of any reduction in either PAH or CB levels in the sediments after 7 months. It is 
possible that flounder in the mesocosms simply did not accumulate sufficient contaminant to 
induce CYP1A, or that induction of CYP1A in specific tissues is dependent on route of 
exposure (VanVeld et al., 1997). Alternatively, CYP1A may become unresponsive after 
long-term exposure to PAH, as has been reported in flounder fed PAH-spiked food which 
demonstrated increases in CYP1A after 1 month, but no effect after 6 months of feeding 
(Reynolds et al., 2003). 
The effects of hepatocyte treatments with prototypical pollutants were very similar to 
hepatic expression profiles from previous studies on acutely exposed whole flounder 
(Williams et al., 2008); supplementary tables 1-4). Importantly, it was clear that the expected 
genes, CYP1A, UGT1B for BAP and vitellogenin, choriogenin for E2 were highly elevated 
(Fig 4). In addition glutathione reductase and GSTA showed very similar treatment-response 
profiles to CYP1A, indicating that in flounder these genes are likely to be regulated by the 
same mechanism as CYP1A, by the aryl hydrocarbon receptor (Beischlag et al., 2008). This 
demonstrates that although these genes were not induced by sediment exposure at 
environmentally relevant concentrations, the systems which regulate them in response to 
contaminants were intact in the isolated hepatocytes. Some interesting interactions between 
sediment and treatments were also apparent, from the microarray data and also confirmed by 
QPCR. For example, whilst vitellogenin mRNA is highly induced by E2 in hepatocytes from 
both polluted and clean fish, it is also induced, albeit to a lesser extent, by BAP and by CU 
in the ‘clean’ hepatocytes, but not in ‘polluted’ hepatocytes. The reasons for this are not 
obvious, although both BAP and its metabolites, and more recently metals, including Cu, 
have been shown to mimic estrogen when present at sufficient concentration (Darbre, 2006) 
(Fertuck et al., 2001). The fact that this response is clearly different depending on hepatocyte 
source, suggest that these effects may extend to fish living in chronically polluted and clean 
environments, and should perhaps be investigated further given the relevance for 
environmental monitoring programs. 
Also apparent are effects of the mixture on hepatocytes. Although this treatment 
induced CYP1A, and UGT1B to the same extent as BAP alone, vitellogenin expression was 
much reduced compared to E2 alone. These types of interactions between pathways which 
depend on the aryl hydrocarbon and estrogen receptors have been previously observed in 
mammals (Safe and Wormke, 2003) (Beischlag and Perdew, 2005). If the same effects are 
seen in fish, as seems evident from the results reported here, then the results of CYP1A and 
vitellogenin biomarker measurements in multiply-polluted environments should be treated 
with caution. 
In addition to biomarker genes associated with acute chemical exposure, we also 
measured by QPCR some of the genes which were associated with clean or polluted 
sediment. As indicated by global clustering of the microarray data, some of these genes 
(Diablo and transthyretin) showed a pattern of expression which was largely dependent on 
sediment of origin, rather than acute treatment. However QPCR results showed that these 
sediment-related genes may also be further modulated by acute exposure. An interesting 
example is Diablo. The expression of this gene was higher in all polluted samples than in 
clean, but following mixture treatment, expression in polluted hepatocytes further increases 
to levels 30 fold higher than in clean vehicle-treated hepatocytes. Diablo (or Smac) is a 
protein released from mitochondria which inhibits the activity of a repressor of caspase 3, a 
major apoptotic executioner (Du et al., 2000). An increase in Diablo might thus be an 
indication that under cell death stimuli, apoptosis is highly favoured. The signals which 
promote increases in Diablo are not known, but as a component of the mitochondrion it is 
likely associated with the intrinsic apoptotic pathway, responding to cellular damage 
(Shiozaki and Shi, 2004), and Diablo mimetics have recently been shown to increase the 
susceptibility of diseased cells to apoptosis-inducing drugs (Fulda et al., 2002) (Bank et al., 
2008). The pattern and magnitude of expression changes in flounder liver indicate that 
Diablo, and the pathways to which it belongs are worthy of further investigation, with the 
prospect of developing more relevant environmental biomarkers. 
 
5. Conclusions 
 
In summary and conclusion we have shown that long-term, chronic exposure of 
flounder to multiply-polluted estuarine sediments causes increases in the hepatic expression 
of genes involved in innate immunity, inflammation and apoptotic pathways. Genes 
commonly employed as environmental contaminant exposure biomarkers (eg CYP1A, 
vitellogenin, metallothionein) were not affected, or were changed contrary to expectation in 
this experimental system, suggesting that they may be most useful in monitoring acute spill, 
or point-source contaminant inputs to the environment. The results of this experiment show 
that, during long-term exposure to diffuse, multiple contaminants there may be other, more 
useful biomarkers of exposure (or effect) which indicate changes in chronic inflammatory 
and apoptotic pathways.  
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Appendix A 
 
Supplementary data detailing the genes whose expression is changed in hepatocytes from 
flounder exposed to clean or polluted sediments are included in Supplementary Tables 1 to 
4. 
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Supplementary Table 1. Hepatocyte genes whose expression changed in response to benzo(a)pyrene treatment 
List and associated numbers were generated by pairwise T-test of gene expression from treated 'clean' or 'polluted' hepatocytes versus untreated 
'clean' hepatocytes and untreated 'polluted' hepatocytes respectively, using an input list from the total list of genes shown to change in response to 
treatment by 2 way ANOVA (FDR p<0.05). The fold increase in hepatocyes from fish held on 'clean' sediment is under the heading 'CleanFold' 
and from polluted sediment 'PollFold'. P values of each pairwise test are also indicated. Only genes which were >2 fold up or down, p<0.05 in 
either hepatocyte group are included. Shading indicates where the response was >2 fold up or down, and where p >0.05. Genes without any 
associated annotation have been omitted from this list. 
      
Array Contig CleanFold PollFold CleanPval PollPval BLAST 
Contig504 14.91 20.37 0.0169 0.0298 CYP1A Cytochrome P450 1A 
PfIL262B03 8.516  1.05 0.0201  0.871 microsatellite DNA, locus StPfl016 
PfIL303G04 6.596  1.057 0.0111  0.794 ReO_6 protein 
PfIL289G08 6.413  1.755 0.00655  0.474 Myeloid/lymphoid or mixed-lineage leukemia protein 4 
Contig297 5.168  1.89 0.00655  0.0754 similar to transient receptor potential cation channel 
Contig525 4.394 4.214 0.0313 0.0261 UDP-glucuronosyltransferase (UGT1B gene) 
Contig765 4.17  0.999 0.00657  0.994 JFMIP1b pseudogene premature mRNA for MIP1beta 
PfIL305H02 3.986  1.79 0.012  0.441 G protein-coupled receptor kinase-interactor 2 isoform 1 
PfIL262G01 3.42  1.871 0.00657  0.0511 Trans-golgi network protein 2 
PfIL248A04 3.356  1.304 0.0208  0.162 Vacuolar protein sorting-associated protein 45 
PfIL232F01 3.265  1.973 0.00734 0.0298 ATPase family, AAA domain containing 4 
PfIL295F02 3.162  1.829 0.00643 0.0477 GTP cyclohydrolase I feedback regulatory protein 
PfIL285F04 3.08  1.001 0.00657  0.994 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa 
PfIL259G06 2.897  1.37 0.00704  0.168 KH-type splicing regulatory protein 
PfIL258B11 2.885  1.532 0.00657 0.0468 Inhibitor of DNA binding 2 
PfIL229D06 2.664  1.428 0.0283  0.0631 anion exchanger 2 
Contig405 2.643  1.498 0.0117  0.053 cDNA clone down072 (sim to pre-acrosome localisation protein?) 
PfIL320H03 2.591  1.425 0.0195 0.042 pleurocidin-like peptide WFYT (ple5, ple6), WF1L (ple7) genes, and ple10 
Contig27 2.56  0.989 0.028  0.99 chemokine (C-X-C motif) ligand 12a 
Contig413 2.546  1.898 0.0092 0.0137 MASP protease / haptoglobin 
Contig423 2.52  1.511 0.00643 0.0259 calreticulin 
PfIL213G03 2.358  0.947 0.0474  0.892 MGC84339 protein 
PfIL295C01 2.329 0.411  0.0642 0.0226 hypothetical protein LOC552925 
PfIL011C04 2.325  1.384 0.011  0.155 splicing factor arginine/serine-rich 3 
PfIL227C08 2.304  0.822 0.00643  0.252 Butyrate response factor 2 
PfIL237C04 2.291  1.929 0.00657 0.034 p24 delta1 putative cargo receptor 
Contig281 2.262  1.279 0.00834  0.17 Heterogeneous nuclear ribonucleoprotein A/B 
PfIL279B01 2.251  1.953 0.0387 0.0298 ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A, like 
Contig870 2.247  1.506 0.0441 0.0396 small ubiquitin-like modifier protein 3; SMT3 
Contig148 2.236  1.368 0.00793  0.185 RAB6A, member RAS oncogene family isoform a 
PfIL292C12 2.205  1.623 0.0277 0.0298 transcription elongation factor B (SIII) polypeptide 2 
PfIL259D04 2.203  1.83 0.00643 0.0298 signal peptidase complex subunit 3 homolog 
Contig291 2.176  1.347 0.00643  0.0871 ER-resident chaperone calreticulin 
PfIL261B02 2.174  1.93 0.00643 0.00619 Probable diphthine synthase 
PfIL227B02 2.165  1.164 0.028  0.355 guanine nucleotide binding protein (G protein), beta polypeptide 1 (gnb1) 
PfIL246G07 2.141  1.465 0.0117 0.034 Phosphomannomutase 2 
Contig273 2.134  1.203 0.00823  0.0963 sister of P-glycoprotein 
PfIL303B09 2.13  1.074 0.0148  0.722 cDNA clone CDA45-H11.y1d-s sim to ubiquitin specific protease 9 
PfIL234A06 2.116  1.739 0.0161  0.116 Karyopherin alpha 5 (importin alpha 6) 
PfIL315E01 2.106  1.458 0.013  0.112 B-lymphocyte activation marker BLAST-1 precursor 
PfIL300G11 2.093  1.805 0.00643 0.034 similar to programmed cell death 6 
PfIL304D07 2.018  1.228 0.0195  0.463 Ring finger protein 10 
PfIL257A11 2.016 2.255  0.0821 0.017 Siah-interacting protein (Sip-prov) 
PfIL232H02 1.959 2.044 0.00823 0.0163 lipocalin-type prostaglandin D synthase-like protein 
PfIL309A08 1.952 2.221 0.0362 0.0259 P-glycoprotein type A pEXI-homologous region 
PfIL301B12 1.884 2.217  0.0596 0.0298 microsomal stress70 protein ATPase core precursor 
Contig597 1.839 2.263 0.0118 0.0137 alpha-1-microglobulin/bikunin precursor 
PfIL273D07 1.765 2.007 0.00768 0.0234 cDNA clone Pf_IL_302B12 5' similar to Acyl-CoA-binding protein 
PfIL278F06 1.76 2.309 0.00835 0.0303 hypothetical protein LOC553776 
PfIL298C06 1.584 2.42  0.121 0.0262 Rb1-inducible coiled coil protein 1 
PfIL254F08 1.554 2.773  0.0751 0.00956 Nf-kappa B activator (TANK) 
Pp002 1.441 3.761  0.199 0.0303 3' untranslated region of GSTA1 
PfIL238F01 1.396 2.06 0.028 0.00992 glutathione S-transferase 
PfIL289E03 1.082 2.543  0.569 0.00619 archipelago CG15010-PC, isoform C 
PfIL308C06 0.7 0.46 0.0415 0.0234 Transmembrane 4 superfamily member 7 
PfIL271G09 0.696 0.308  0.318 0.0378 Ubiquitin specific protease 16 
PfIL243B02 0.586 0.28  0.117 0.0163 immunoglobulin D heavy chain 
Contig864 0.54 0.442 0.00793 0.0331 Phospholipase A2 precursor 
PfIL250G09 0.536 0.476  0.0642 0.0176 carboxypeptidase A1 (poor seq) 
Contig1106 0.534 0.486 0.00657 0.00992 actin related protein 2/3 complex subunit 5, 16 kDa 
Contig527 0.52 0.435 0.0116 0.00422 type II keratin 
Contig633 0.505 0.477 0.0276 0.0153 Chymotrypsin B precursor 
PfIL209E08 0.5 0.378 0.047 0.0345 6-pyruvoyl tetrahydrobiopterin synthase 
PfIL236A07 0.499  0.739 0.00734  0.0975 DnaJ (Hsp40) homolog, subfamily C, member 1 
Contig316 0.497  0.606 0.00657 0.0137 chemotaxin 
PfIL223D11 0.497  0.621 0.0302  0.053 eukaryotic translation initiation factor 4E binding protein 1 
Contig681 0.495 0.483 0.0177 0.0298 Elastase 1 
PfIL276A07 0.493 0.482 0.0354 0.0348 phosphatidate phosphohydrolase type 2a 
Contig686 0.491  0.832 0.0208  0.173 40S ribosomal protein S2 
Contig914 0.489 0.492 0.0171 0.033 trypsinogen 2 precursor 
Contig718 0.484  0.676 0.0161 0.0381 anticoagulant protein C precursor (PROC) 
PfIL251H03 0.482  0.536 0.0309 0.0303 unnamed protein product CAG01129 
PfIL315H04 0.481  0.833 0.0121  0.425 Delta3,5-delta2,4-dienoyl-CoA isomerase, mitochondrial precursor 
PfRHO-o1 0.48  0.611 0.0133 0.0298 Rho 
PfIL298B07 0.474  0.743 0.0119  0.145 apolipoprotein H precursor 
Contig1074 0.474  0.665 0.0157 0.0137 Coronin 1A 
Contig473 0.474  0.73 0.00704  0.109 C-type lectin 1 
Contig738 0.474 0.397 0.00657 0.0298 High choriolytic enzyme 1 precursor 
PfIL227F02 0.473 0.492 0.00657 0.0259 complement component 1 q subcomponent 
PfIL006C07 0.472  0.593 0.0239 0.0346 clone sp006sk 5' similar to Coronin, actin binding protein, 1A  
Contig1079 0.467 0.417 0.00835 0.0298 trypsinogen 2 precursor 
PfIL241D10 0.464  0.62 0.0123 0.00618 arginase, type I; A-I 
Contig648 0.462 0.459 0.00957 0.0334 carboxypeptidase A1 
Contig78 0.461 0.248 0.0389  0.148 immunoglobulin light chain L2 
PfIL298D09 0.46 0.405 0.00614 0.0137 NADH dehydrogenase subunit 2 
PfIL291C08 0.458  0.979 0.013  0.93 Glutathione S-transferase, theta 3 
PfIL273H09 0.454  0.698 0.00823  0.0629 Hsc70-interacting protein (Hip) 
PfIL012H08 0.451  0.785 0.0116  0.551 inhibitor of differentiation 1C; Id 6-2 
PfIL217A03 0.45  0.743 0.0123  0.0561 Chaperonin containing TCP1, subunit 3 (Gamma 
PfIL209A06 0.44  0.68 0.0156  0.0648 Asparaginyl-tRNA synthetase 
Contig774 0.44  0.552 0.0106 0.02 MHC II invariant chain 
PfIL241E06 0.435 0.471 0.025  0.151 Golgi transport 1 homolog A 
Contig975 0.435  0.627 0.00614  0.0572 trypsin III 
Contig629 0.432  0.583 0.0126 0.038 prothrombin precursor 
Contig624 0.427 0.458 0.0116  0.0754 Sulfatase modifying factor 2 precursor 
Pp007 0.426  0.676 0.00657  0.0508 UDP - glucose phosphatase 
Contig919 0.419 0.482 0.00682 0.034 Chymotrypsinogen 1 
Contig330 0.418  0.625 0.00823  0.0645 Asparaginyl-tRNA synthetase 
Contig474 0.417  0.684 0.00657 0.0362 Perforin 1 precursor (P1) (Lymphocyte pore forming protein) (Cytolysin) 
PfIL209A08 0.412  0.579 0.0106 0.0298 ATP binding protein associated with cell differentiation 
Contig986 0.41 0.441 0.00657 0.0181 bile salt-activated lipase (BAL) 
PfIL202H02 0.408  0.588 0.00695  0.0724 chaperonin containing TCP-1 delta 
PfSHA2F7 0.407 0.492 0.00614  0.0568 Antifreeze glycoprotein precursor 
PfIL279B04 0.407  0.501 0.0116 0.0212 Phospholipase A2 
PfIL253F11 0.404 0.487 0.0127 0.00992 NADH dehydrogenase subunit 3 
Pa016 0.403  0.643 0.0116 0.0352 Cytochrome P450 2X 
Contig693 0.401 0.443 0.0258 0.0396 selenoprotein M 
Contig418 0.396 0.372 0.013 0.0298 Alpha amylase 
Pp005 0.394  0.615 0.0111 0.0378 Fatty acid binding protein 
Contig885 0.393  0.522 0.00614 0.034 Perforin 
Contig1060 0.388 0.434 0.00657  0.0511 trypsin 
Contig447 0.388  0.551 0.0149 0.0226 unnamed protein product CAG03272 
Contig346 0.383  0.571 0.00657  0.307 unnamed protein product CAF90585 
Contig804 0.382 0.266 0.00643 0.00619 immunoglobulin light chain precursor 
PfIL263A03 0.38  0.692 0.00834  0.145 poly A binding protein, cytoplasmic 1 
PfIL243F11 0.379  0.732 0.0357  0.474 Kruppel-like factor 2a klf2a 
Contig1049 0.37 0.485 0.00669 0.0298 Chymotrypsinogen 2 
PfFMO2-ll0 0.37 0.44 0.0116 0.0303 inter-alpha-trypsin inhibitor heavy chain 2 
Contig744 0.367  0.608 0.00657 0.0286 cDNA clone CR729877 sim to fibrinogen, alpha chain isoform alpha-E 
PfILCOMA06 0.367  0.627 0.00643  0.0856 perforin 
Contig467 0.364  0.504 0.00643 0.0303 Deoxyribonuclease I precursor (DNase I) 
Contig568 0.355 0.438 0.00682 0.0298 Carboxypeptidase A2 
PfIL218F05 0.329  0.561 0.00797 0.0298 P18 splicing regulatory protein 
PfIL307D04 0.326  0.669 0.0146  0.127 irn70ks / 18S rRNA (poor seq) 
Contig998 0.321 0.356 0.00643 0.0259 Elastase 3 
Contig1091 0.315 0.428 0.00657 0.0298 elastase A precursor 
Contig1108 0.312 0.363 0.0119 0.0176 elastase 2-like protein 
Contig903 0.292  0.564 0.0116 0.0259 ribosomal RNA 
PfIL007A06 0.289 0.433 0.0106 0.0298 carboxypeptidase B 
PfIL306D01 0.288  0.98 0.00677  0.914 18S ribosomal RNA 
PfIL214A05 0.285  0.633 0.00643  0.0677 18S ribosomal RNA 
PfIL245C07 0.282 0.327 0.00643 0.0107 Integrin alpha5 
PfIL259C04 0.281 0.329 0.00614 0.0298 elastase 2 precursor 
Contig22 0.216  0.593 0.00643 0.0298 metallothionein 
PfIL288C01 0.181 0.178 0.00366 0.0164 type I keratin S8 
 
Supplementary Table 1. Hepatocyte genes whose expression changed in response to estradiol treatment 
List and associated numbers were generated by pairwise T-test of gene expression from treated 'clean' or 'polluted' hepatocytes versus untreated 
'clean' hepatocytes and untreated 'polluted' hepatocytes respectively, using an input list from the total list of genes shown to change in response to 
treatment by 2 way ANOVA (FDR p<0.05). The fold increase in hepatocyes from fish held on 'clean' sediment is under the heading 'CleanFold' and 
from polluted sediment 'PollFold'. P values of each pairwise test are also indicated. Only genes which were >2 fold up or down, p<0.05 in either 
hepatocyte group are included. Shading indicates where the response was >2 fold up or down, and where p >0.05. Genes without any associated 
annotation have been omitted from this list. 
      
Array Contig CleanFold PollFold CleanPval PollPval BLAST 
PfIL257D11 63.06 45.17 0.00257 0.0367 Vitellogenin 
Contig458 50.74 37.97 0.00215 0.0187 Vitellogenin 
Contig398 16.68 17.12 0.00257 3.62E-05 choriogenin L 
Contig450 10.67 11.02 0.00215 0.0169 Vitellogenin 
Contig403 3.987 3.094 0.0215 0.0169 IgM heavy chain constant region 
PfIL304D06 3.035 2.756 0.0387 0.0338 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 
Contig457 2.716  1.494 0.0178 0.0466 CDA08-B12.y1d-s SHGC-CDA sim to hippocalcin-like 1 
PfIL013A02 2.147  1.652 0.0163 0.0169 Oligosaccharyl transferase 48 kDa subunit 
PfIL238C10 2.057  1.736 0.0234 0.0377 Hypothetical protein zgc:77713 
PfIL237C04 2.049  1.788 0.0274 0.00544 p24 delta1 putative cargo receptor 
PfIL255E12 2.028  1.548 0.0169 0.0169 heat shock protein gp96 
PfIL262G01 1.878 2.135  0.185 0.0338 Trans-golgi network protein 2 
PfIL271G09 0.668 0.32  0.12 0.0378 Ubiquitin specific protease 16 
Contig750 0.656 0.494  0.12 0.0378 Tetraspan 1 
PfIL307D04 0.582 0.472  0.283 0.0275 irn70ks / 18S rRNA (poor seq) 
PfIL218F05 0.498 0.369 0.0169 0.0161 P18 splicing regulatory protein 
PfIL263E08 0.447  0.63 0.0485 0.0157 DnaJ (Hsp40) homolog, subfamily B, member 1 
Contig903 0.398 0.47 0.0113 0.0152 ribosomal RNA 
PfIL245C07 0.372  0.523 0.00685 0.0169 Integrin alpha5 
PfIL214A05 0.353 0.484 0.0169 0.0378 18S ribosomal RNA 
Contig22 0.348 0.316 0.00676 0.00766 metallothionein 
PfIL302H09 0.291  0.527 0.0115 0.0356 RAP1B, member of RAS oncogene family 
 
Supplementary Table 1. Hepatocyte genes whose expression changed in response to copper treatment 
List and associated numbers were generated by pairwise T-test of gene expression from treated 'clean' or 'polluted' hepatocytes versus untreated 'clean' 
hepatocytes and untreated 'polluted' hepatocytes respectively, using an input list from the total list of genes shown to change in response to treatment by 2 way 
ANOVA (FDR p<0.05). The fold increase in hepatocyes from fish held on 'clean' sediment is under the heading 'CleanFold' and from polluted sediment 
'PollFold'. P values of each pairwise test are also indicated. Only genes which were >2 fold up or down, p<0.05 in either hepatocyte group are included. Shading 
indicates where the response was >2 fold up or down, and where p >0.05. Genes without any associated annotation have been omitted from this list. 
      
Array Contig      CleanFold PollFold CleanPval PollPval BLAST
PfIL303G04 3.892 0.892 0.0348  0.276 ReO_6 protein 
PfIL289G08 3.635  1.065 0.0348  0.703 Myeloid/lymphoid or mixed-lineage leukemia protein 4 
PfIL304D06 3.488  1.665 0.0378  0.215 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 
Contig403 3.13 2.709 0.0349  0.0835 IgM heavy chain constant region 
Contig297 3.057  1.45 0.0401  0.435 similar to transient receptor potential cation channel 
PfIL303B09 2.987  1.638 0.0332  0.336 cDNA clone CDA45-H11.y1d-s sim to ubiquitin specific protease 9 
Contig870 2.872  1.686 0.0218  0.222 small ubiquitin-like modifier protein 3; SMT3 
PfIL213G03 2.794 2.603 0.025  0.151 MGC84339 protein 
PfIL259G06 2.75 2.149 0.0428  0.162 KH-type splicing regulatory protein 
PfIL295C01 2.725  0.705 0.0473  0.476 hypothetical protein LOC552925 
PfIL227B02 2.706 2.012 0.0226  0.117 guanine nucleotide binding protein (G protein), beta polypeptide 1 (gnb1) 
Contig765 2.654  0.952 0.0401  0.438 JFMIP1b pseudogene premature mRNA for MIP1beta 
PfIL229C08 2.607  1.08 0.0348  0.556 clone uogacrs-8c7-1 
PfIL262G01 2.552  1.387 0.0348  0.322 Trans-golgi network protein 2 
PfIL233G09 2.482 4.638 0.0332  0.118 formin-binding protein 17 (rapostlin) 
PfIL303A02 2.356 3.072 0.0463  0.17 cDNA clone 1RT138K09_A_F05 sim to taurine transporter (poor seq) 
PfIL013A02 2.318  1.696 0.025 0.0745 Oligosaccharyl transferase 48 kDa subunit 
PfIL227C08 2.313  1.316 0.00993  0.31 Butyrate response factor 2 
Contig281 2.263  1.722 0.0332  0.15 Heterogeneous nuclear ribonucleoprotein A/B 
PfIL246G07 2.169  1.459 0.0417  0.151 Phosphomannomutase 2 
Contig1052 2.096  1.131 0.0348  0.636 cDNA clone CIWU128 similar to keratin associated protein 4-12 
PfIL292C12 2.079  1.967 0.0378  0.0669 transcription elongation factor B (SIII) polypeptide 2 
PfIL011C04 2.077  1.709 0.025  0.151 splicing factor arginine/serine-rich 3 
PfIL243B02 2.061  0.739 0.0409  0.549 immunoglobulin D heavy chain 
PfIL001E05 1.962 2.035  0.0515 0.00677 RAP1A, member of RAS oncogene family 
PfIL278D10 0.497 0.422 0.0348  0.159 NADH dehydrogenase (ubiquinone) Fe-S protein 4 
PfFMO2-ll0 0.491 0.464 0.0348  0.151 inter-alpha-trypsin inhibitor heavy chain 2 
Contig1049 0.484  0.729 0.0348  0.14 Chymotrypsinogen 2 
PfIL306D01 0.46  0.575 0.0348  0.157 18S ribosomal RNA 
PfIL265A10 0.454  0.738 0.0463  0.133 Hypothetical protein MGC40107 
Contig1060 0.45  0.712 0.0348  0.363 trypsin 
Contig903 0.434  0.506 0.0382  0.14 ribosomal RNA 
Contig424 0.426  0.651 0.0348 0.0213 low molecular weight heat shock protein Hsp30B 
Contig1091 0.417  0.73 0.0348  0.211 elastase A precursor 
Contig998 0.415  0.675 0.0453  0.14 Elastase 3 
PfIL307D04 0.407  0.63 0.0348  0.266 irn70ks / 18S rRNA (poor seq) 
PfIL298D09 0.405 0.409 0.0348  0.0745 NADH dehydrogenase subunit 2 
SSH control 
DNA 0.361  1.493 0.0347  0.565 SSH control DNA 
PfH70-g1 0.333  0.586 0.0473  0.246 heat shock protein 70 
PfIL313F10 0.273 0.306 0.0349  0.207 Rho GTPase activating protein 19 
PfIL218F05 0.268 0.478 0.025 0.0669 P18 splicing regulatory protein 
Contig22 0.176 0.448 0.022 0.0745 metallothionein 
 
Supplementary Table 1. Hepatocyte genes whose expression changed in response to mixture treatment 
List and associated numbers were generated by pairwise T-test of gene expression from treated 'clean' or 'polluted' hepatocytes versus untreated 'clean' 
hepatocytes and untreated 'polluted' hepatocytes respectively, using an input list from the total list of genes shown to change in response to treatment by 2 way 
ANOVA (FDR p<0.05). The fold increase in hepatocyes from fish held on 'clean' sediment is under the heading 'CleanFold' and from polluted sediment 
'PollFold'. P values of each pairwise test are also indicated. Only genes which were >2 fold up or down, p<0.05 in either hepatocyte group are included. Shading 
indicates where the response was >2 fold up or down, and where p >0.05. Genes without any associated annotation have been omitted from this list. 
      
Array Contig CleanFold PollFold CleanPval PollPval BLAST 
Contig504 16.7 19.55 0.0174 0.00264 CYP1A Cytochrome P450 1A 
Contig458 11.15 6.777 0.0137  0.121 Vitellogenin 
PfIL257D11 9.263 6.244 0.006 0.0577 Vitellogenin 
Contig525 6.841 4.533 0.0201  0.118 UDP-glucuronosyltransferase (UGT1B gene) 
Contig398 6.476 6.184 0.0131 0.0155 choriogenin L 
PfIL309A08 4.122  1.74 0.00564 0.0479 P-glycoprotein type A pEXI-homologous region 
PfIL301B12 2.773 2.806 0.019 0.00607 microsomal stress70 protein ATPase core precursor 
PfIL263A08 2.693  1.623 0.0222 0.0412 clone cmcon186 microsatellite sequence 
PfIL257A11 2.659 2.091 0.00771  0.156 Siah-interacting protein (Sip-prov) 
Contig413 2.455  1.771 0.0144  0.0758 MASP protease / haptoglobin 
Contig492 2.442 2.067 0.00796 0.0155 c-Fos 
PfIL261A12 2.324  1.234 0.0139  0.511 Cytochrome b5 
PfIL273D07 2.311  1.675 0.0186 0.0168 cDNA clone Pf_IL_302B12 5' similar to Acyl-CoA-binding protein 
Contig969 2.238  1.355 0.0133 0.0199 similar to HIG1 domain family, member 2A 
PfIL257G07 2.221  1.009 0.0179  0.876 cDNA clone up050 similar to PTPRJ 
PfIL308C03 2.187  1.738 0.0119  0.0601 Annexin A11b 
PfIL011H10 2.164 2.136 0.0137 0.043 DnaJ-like subfamily A member 4 (Hsp40A4) 
PfIL237C04 2.156 2.032 0.00771 0.0457 p24 delta1 putative cargo receptor 
PfIL278F06 2.151 2.314 0.00835 0.0178 hypothetical protein LOC553776 
PfIL223G08 2.13 2.495 0.006 0.0622 similar to transthyretin (4L369) 
Contig678 2.116  1.174 0.006  0.656 NADPH oxidase flavocytochrome b small subunit p22phox 
PfIL261B02 2.097  1.428 0.0274  0.15 Probable diphthine synthase 
Contig405 2.092 2.181 0.0247 0.016 cDNA clone down072 (sim to pre-acrosome localisation protein?) 
PfIL260G05 2.08  0.909 0.0464  0.417 14 kDa apolipoprotein 
PfIL300G11 2.072  1.632 0.00564  0.171 similar to programmed cell death 6 
Contig952 2.07  1.851 0.0202  0.157 18S ribosomal RNA gene 
Contig57 2.04  1.69 0.0139 0.016 phenylalanine hydroxylase 
Contig752 2.023  1.631 0.0264  0.0636 Liver-expressed antimicrobial peptide 2A 
PfIL259D04 2.012  1.622 0.011 0.0734 signal peptidase complex subunit 3 homolog 
Contig459 2.006  1.909 0.0242  0.0772 Peroxiredoxin (Thioredoxin peroxidase) (NKeF) 
PfIL285E11 2.004  1.623 0.0107 0.0182 Transmembrane protein 4 TMEM4 
PfIL298C06 1.784 2.103  0.0632 0.0161 Rb1-inducible coiled coil protein 1 
PfIL241D10 1.694 2.001 0.0152 0.00264 arginase, type I; A-I 
PfIL254F08 1.518 2.367  0.203 0.0088 Nf-kappa B activator (TANK) 
PfIL320H03 1.496 2.063  0.128 0.0109 pleurocidin-like peptide WFYT (ple5, ple6), WF1L (ple7) genes, and ple10 
Contig357 1.328 2.017  0.183 0.0088 Cystathionine-beta-synthase 
PfH70-g1 1.196 2.725  0.692 0.0088 heat shock protein 70 
PfIL259A02 1.102 2.119  0.431 0.0173 Proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 
PfIL012C12 0.785 0.411  0.373 0.00823 S100-like calcium binding protein 
PfIL309H12 0.782 0.448  0.152 0.0276 MHC class II alpha 
Contig801 0.779 0.399  0.155 0.0199 Protein phosphatase 1, regulatory (inhibitor) subunit 3B 
PfIL295C01 0.768 0.492  0.495 0.00823 hypothetical protein LOC552925 
PfIL217D10 0.761 0.382  0.0573 0.0199 unnamed protein product CAF91835 (EST OD-118) 
PfIL224F02 0.755 0.455  0.359 0.0179 ZPAX 
Contig495 0.719 0.462  0.245 0.0268 Calcium binding protein, glucose regulated protein GRP170 precursor 
Contig885 0.697 0.47 0.0315 0.0199 Perforin 
PfIL050E09 0.689 0.465 0.0311 0.0199 bad sequence 
Contig44 0.683 0.441 0.0455 0.00607 chemotaxin 
Contig925 0.676 0.473 0.0264 0.00636 unnamed protein product CAG03272 
Contig1049 0.648 0.468 0.0294 0.0183 Chymotrypsinogen 2 
Contig403 0.617 0.345 0.0258 0.027 IgM heavy chain constant region 
PfIL236A07 0.608 0.435 0.0215 0.0161 DnaJ (Hsp40) homolog, subfamily C, member 1 
Contig316 0.601 0.43 0.0392 0.00607 chemotaxin 
Contig441 0.579 0.46 0.0208 0.00607 hepcidin precursor 
Contig693 0.573 0.396  0.0597 0.0216 selenoprotein M 
Contig447 0.569 0.46 0.0133 0.00607 unnamed protein product CAG03272 
Contig397 0.538 0.317 0.006 0.00264 unnamed protein product CAG03272 
Contig470 0.526 0.471 0.0281 0.0232 hepcidin-like precursor 
Contig1108 0.51 0.48 0.006 0.0355 elastase 2-like protein 
PfIL319D08 0.51 0.435 0.0432 0.0162 kelch-like 9 
PfIL217A03 0.496  0.709 0.00837 0.026 Chaperonin containing TCP1, subunit 3 (Gamma 
Contig418 0.495  0.585 0.00564 0.0381 Alpha amylase 
PfIL263G01 0.489 0.368 0.00837 0.0199 T-lymphocyte antigen receptor beta-chain constant region 2 
Contig1074 0.488  0.594 0.0292 0.0332 Coronin 1A 
Contig205 0.486 0.431 0.00564 0.0083 NADPH oxidase cytosolic protein p67phox 
PfRHO-o1 0.486  0.557 0.0242 0.0176 Rho 
PfIL007A06 0.485 0.454 0.0475 0.0199 carboxypeptidase B 
Contig998 0.483 0.428 0.0142 0.0183 Elastase 3 
Contig824 0.48  0.689 0.0179  0.195 Immunoglobulin lambda-like polypeptide 1 precursor 
PfIL226G02 0.479  0.803 0.0258  0.362 carboxypeptidase N, polypeptide 1, 50kD precursor 
PfIL298D09 0.477  1.113 0.0102  0.343 NADH dehydrogenase subunit 2 
Contig427 0.476 0.403 0.00946 0.00607 hepcidin-like precursor 
PfIL285A07 0.476 0.465 0.0292  0.0622 Lysozyme c (poor seq) 
PfIL308C06 0.475 0.376 0.006 0.0126 Transmembrane 4 superfamily member 7 
PfIL259C04 0.468 0.442 0.00837 0.026 elastase 2 precursor 
Contig633 0.467  0.521 0.00697  0.0819 Chymotrypsin B precursor 
PfIL318A02 0.467  0.736 0.0137  0.0933 Hypothetical protein zgc:73259 
PfIL318D02 0.466  0.703 0.0412  0.223 Elastase 1 
PfIL260F08 0.466  0.549 0.0113 0.0381 hypothetical protein LOC406709 
Contig738 0.461  0.567 0.0139 0.028 High choriolytic enzyme 1 precursor 
PfIL223G10 0.458  0.622 0.0208  0.07 Leucine-rich alpha-2-glycoprotein 1 
(likely 
lysozyme c) 0.449  0.53 0.006 0.00607 (likely lysozyme c) 
Contig181 0.447  0.516 0.0258 0.0115 gelatinase, matrix metalloproteinase 9 
Contig1060 0.445 0.488 0.00796  0.0573 trypsin 
Contig1106 0.441 0.443 0.00835 0.0199 actin related protein 2/3 complex subunit 5, 16 kDa 
Contig747 0.44  0.625 0.0264 0.0355 Myo-inositol monophosphatase 
Contig41 0.439  0.566 0.00771 0.00636 Lysozyme c 
Contig994 0.429 0.477 0.0179 0.00888 glyceraldehyde 3-phosphate dehydrogenase, GAPDH 
Contig527 0.423 0.419 0.00564 0.0332 type II keratin 
PfIL211F10 0.419  0.833 0.006  0.531 importin 9 
Contig429 0.418 0.389 0.0144 0.00607 hepcidin precursor 
Contig774 0.416  0.53 0.0208 0.0216 MHC II invariant chain 
PfIL243B02 0.412 0.234 0.0242 0.0126 immunoglobulin D heavy chain 
Contig685 0.408 0.472 0.0119 0.0276 High choriolytic enzyme 1 precursor 
Pp005 0.405  0.512 0.0294 0.0479 Fatty acid binding protein 
PfIL277H02 0.405 0.484 0.0452 0.028 Ubiquitin-protein ligase RMA1 
PfIL290E09 0.401  0.54 0.0311 0.0126 Myeloid-associated differentiation marker 
PfIL276A07 0.396 0.481 0.006 0.0293 phosphatidate phosphohydrolase type 2a 
PfIL202H02 0.394  0.564 0.0186  0.0879 chaperonin containing TCP-1 delta 
PfIL251H03 0.369 0.417 0.0345 0.0176 unnamed protein product CAG01129 
Contig346 0.365 0.461 0.019  0.188 unnamed protein product CAF90585 
Contig624 0.35  0.648 0.0322  0.224 Sulfatase modifying factor 2 precursor 
PfIL227F02 0.343 0.496 0.0345  0.0758 complement component 1 q subcomponent 
PfIL305B08 0.338  0.896 0.0133  0.536 GATA-binding protein 6 
PfIL245C07 0.324 0.33 0.00606 0.0126 Integrin alpha5 
PfIL249C07 0.311  0.609 0.00564  0.212 nucleoporin 214kDa 
PfIL313F10 0.301 0.204 0.0397  0.0844 Rho GTPase activating protein 19 
PfIL214A05 0.296  0.705 0.006  0.376 18S ribosomal RNA 
Contig804 0.269 0.212 0.00796 0.000757 immunoglobulin light chain precursor 
PfIL288C01 0.131 0.116 0.006 0.00607 type I keratin S8 
 
